Literature DB >> 8586129

Role of bronchoalveolar lavage in children with lung disease.

J Riedler1, J Grigg, C F Robertson.   

Abstract

The aim of the present study was to evaluate the clinical role of bronchoscopic and nonbronchoscopic bronchoalveolar lavage (BAL) in the diagnosis of infectious and interstitial lung disease in children. BAL was performed using three 1 mL.kg-1 aliquots of normal saline, with the flexible bronchoscope (Olympus 3.6 or 4.8 mm) wedged in a segmental or subsegmental bronchus of the lobe that showed most abnormality on chest radiograph. In seven children with severe diffuse lung disease who were intubated, a nonbronchoscopic suction catheter lavage was performed. Fluid cultures and cellularity were evaluated using identical methods for both techniques. Between January 1993 and April 1994, 41 BAL were performed in 32 children aged 2 months to 17 yrs (median 8 yrs). Of these lavages, 14 were in heart and heart-lung transplant recipients, 11 in children known to be immunocompromised, and 16 in children who had a lung biopsy for interstitial lung disease or who had presumed infective lung disease. Transbronchial biopsies (TBB) or open lung biopsies were performed coincident with 19 BAL procedures. In all transplant recipients without clinical symptoms, BAL and TBB cultures were negative and BAL cellularity was normal. TBB did not reveal infection or rejection in any of these patients. A diagnosis of infection was made by BAL in 1 out of 8 transplant recipients with clinical symptoms, and a diagnosis of rejection was made by TBB in 3 out of 8 patients. In 6 out of 11 BAL in immunocompromised children, an infectious agent was found in the BAL fluid. In three other patients who had an open lung biopsy, an interstitial lung disease was diagnosed. In these patients, BAL was abnormal but not diagnostic. In summary, BAL proved helpful in the diagnosis of infective lung disease, but had little value in the diagnosis of rejection or parenchymal noninfective lung disease in children.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586129     DOI: 10.1183/09031936.95.08101725

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

1.  Investigation of the child with interstitial lung disease.

Authors:  D Spencer; A Fall
Journal:  Indian J Pediatr       Date:  2000-02       Impact factor: 1.967

2.  Comparison of two aspiration techniques of bronchoalveolar lavage in children.

Authors:  Christian Rosas-Salazar; Stephen A Walczak; Daniel G Winger; Geoffrey Kurland; Jonathan E Spahr
Journal:  Pediatr Pulmonol       Date:  2013-10-24

Review 3.  An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy.

Authors:  Geoffrey Kurland; Robin R Deterding; James S Hagood; Lisa R Young; Alan S Brody; Robert G Castile; Sharon Dell; Leland L Fan; Aaron Hamvas; Bettina C Hilman; Claire Langston; Lawrence M Nogee; Gregory J Redding
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

Review 4.  Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients.

Authors:  Elizabeth Foglia; Mary Dawn Meier; Alexis Elward
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

5.  Airway cellularity, lipid laden macrophages and microbiology of gastric juice and airways in children with reflux oesophagitis.

Authors:  A B Chang; N C Cox; J Purcell; J M Marchant; P J Lewindon; G J Cleghorn; L C Ee; G D Withers; M K Patrick; J Faoagali
Journal:  Respir Res       Date:  2005-07-15

Review 6.  Innate Immunity to Respiratory Infection in Early Life.

Authors:  Laura Lambert; Fiona J Culley
Journal:  Front Immunol       Date:  2017-11-14       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.